Reported Reactions

Devices › Device types

FDA product code PFV · class 3 · Unknown

System, endovascular graft, arteriovenous (av) dialysis access circuit stenosis treatment: medical device reports filed with FDA

2,762 reports carry this product code, 2014–2026; 8 brands with a page.

2,762
reports with this product code
0% of all MAUDE reports
269
reports, 12 months to August 2026
175 in the 12 months before
68.3%
classified as malfunction
62.3% across all reports
1.1%
classified as death, as reported
0.9% across all reports

Product code PFV is FDA's classification for "System, endovascular graft, arteriovenous (av) dialysis access circuit stenosis treatment" (unknown panel), a class 3 device. 2,762 medical device reports carry this product code, 0% of the MAUDE database, from September 2014 to August 2026.

269 reports arrived in the 12 months to August 2026, up 54% from 175 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (68.3%), injury (30.6%) and death (1.1%). 8 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Fluency Plus Vascular Stent Graft734640.4%92%
Fluency Plus Endovascular Stent Graft635350.6%88.2%
Gore Viabahn Endoprosthesis - 335303.1%31.9%
Covera Vascular Covered Stent338420.3%57.4%
GORE VIABAHN Endoprosthesis164185.8%23.5%
GORE VIABAHN Endoprosthesis with HEPARIN Bioactive Surface961742.1%50%
Flair Endovascular Stent Graft5600.3%78.9%
GORE VIABAHN Endoprosthesis with PROPATEN Bioactive Surface24910.6%40.5%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Angiomed & Medizintechnik Kg1,49254%
W L Gore & Associates62922.8%
Bard Peripheral Vascular50618.3%
Merit Medical Systems893.2%
Bolton Medical10%

Reports by month, five years

02346Sep 2021: 33Oct 2021: 31Nov 2021: 22Dec 2021: 202022Jan 2022: 14Feb 2022: 32Mar 2022: 23Apr 2022: 27May 2022: 21Jun 2022: 25Jul 2022: 22Aug 2022: 22Sep 2022: 20Oct 2022: 22Nov 2022: 20Dec 2022: 132023Jan 2023: 18Feb 2023: 25Mar 2023: 26Apr 2023: 30May 2023: 21Jun 2023: 17Jul 2023: 18Aug 2023: 19Sep 2023: 15Oct 2023: 12Nov 2023: 13Dec 2023: 152024Jan 2024: 11Feb 2024: 6Mar 2024: 15Apr 2024: 31May 2024: 14Jun 2024: 23Jul 2024: 30Aug 2024: 29Sep 2024: 9Oct 2024: 11Nov 2024: 15Dec 2024: 152025Jan 2025: 10Feb 2025: 12Mar 2025: 20Apr 2025: 15May 2025: 13Jun 2025: 12Jul 2025: 14Aug 2025: 29Sep 2025: 23Oct 2025: 14Nov 2025: 17Dec 2025: 142026Jan 2026: 7Feb 2026: 15Mar 2026: 19Apr 2026: 19May 2026: 29Jun 2026: 35Jul 2026: 46Aug 2026: 31

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death1.1%31
Injury30.6%845
Malfunction68.3%1,886
Other0%0
Not given0%0

Who filed

Manufacturer report99.4%2,745
Voluntary report0.3%7
User facility report0%0
Distributor report0%0
Not given0.4%10

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Positioning failure86831.4%
Misfire83630.3%
Fracturea broken bone57420.8%
Breakthe device broke37413.5%
Detachment of device or device componentpart of the device came off1886.8%
Material deformation1786.4%
Activation failure1696.1%
Material perforation1545.6%
Obstruction of flow1334.8%
Malposition of device893.2%
Difficult to removethe device was hard to remove853.1%
Difficult or delayed positioning762.8%
Complete blockage752.7%
Loss of or failure to bond752.7%
Retraction problem592.1%
Insufficient device problem information471.7%
Patient-device incompatibilitythe device did not suit the patient471.7%
Difficult to advance451.6%
Positioning problem441.6%
Activation, positioning or separation problem391.4%

Questions about system, endovascular graft, arteriovenous (av) dialysis access circuit stenosis treatment reports

What is product code PFV?

FDA's classification code for "System, endovascular graft, arteriovenous (av) dialysis access circuit stenosis treatment", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.

How many reports carry this code?

2,762 reports through August 2026, 269 of them in the latest 12 months.

Which brands appear most often?

Fluency Plus Vascular Stent Graft (734), Fluency Plus Endovascular Stent Graft (635), Gore Viabahn Endoprosthesis - 3 (353), Covera Vascular Covered Stent (338) and GORE VIABAHN Endoprosthesis (164). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.